 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
2vrm
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Structure of human mao b in complex with phenyethylhydrazine
|
|
Structure:
|
 |
Amine oxidase [flavin-containing] b. Chain: a, b. Synonym: monoamine oxidase type b, mao-b, monoamine oxidase b. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: pichia pastoris. Expression_system_taxid: 4922
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.201
|
R-free:
|
0.246
|
|
|
Authors:
|
 |
C.Binda,J.Wang,M.Li,F.Hubalek,A.Mattevi,D.E.Edmondson
|
|
Key ref:
|
 |
C.Binda
et al.
(2008).
Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B.
Biochemistry,
47,
5616-5625.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Apr-08
|
Release date:
|
22-Apr-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P27338
(AOFB_HUMAN) -
Amine oxidase [flavin-containing] B
|
|
|
|
Seq: Struc:
|
 |
 |
 |
520 a.a.
499 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.4.3.4
- Monoamine oxidase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2
|
 |
 |
 |
 |
 |
RCH(2)NHR'
|
+
|
H(2)O
|
+
|
O(2)
|
=
|
RCHO
|
+
|
R'NH(2)
|
+
|
H(2)O(2)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
FAD
|
 |
 |
 |
 |
 |
FAD
Bound ligand (Het Group name =
FAD)
corresponds exactly
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
6 terms
|
 |
|
Biological process
|
oxidation reduction
|
11 terms
|
 |
|
Biochemical function
|
electron carrier activity
|
5 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
47:5616-5625
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B.
|
|
C.Binda,
J.Wang,
M.Li,
F.Hubalek,
A.Mattevi,
D.E.Edmondson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure and mechanism of human monoamine oxidase B (MAO B) inhibition by
hydrazines are investigated and compared with data on human monoamine oxidase A
(MAO A). The inhibition properties of phenylethylhydrazine, benzylhydrazine, and
phenylhydrazine are compared for both enzymes. Benzylhydrazine is bound more
tightly to MAO B than to MAO A, and phenylhydrazine is bound weakly by either
enzyme. Phenylethylhydrazine stoichiometrically reduces the covalent FAD
moieties of MAO A and of MAO B. Molecular oxygen is required for the inhibition
reactions, and the level of O2 consumption for phenylethylhydrazine is 6-7-fold
higher with either MAO A or MAO B than for the corresponding reactions with
benzylhydrazine or phenylhydrazine. Mass spectral analysis of either inhibited
enzyme shows the major product is a single covalent addition of the hydrazine
arylalkyl group, although lower levels of dialkylated species are detected.
Absorption and mass spectral data of the inhibited enzymes show that the FAD is
the major site of alkylation. The three-dimensional (2.3 A) structures of
phenylethylhydrazine- and benzylhydrazine-inhibited MAO B show that alkylation
occurs at the N(5) position on the re face of the covalent flavin with loss of
the hydrazyl nitrogens. A mechanistic scheme is proposed to account for these
data, which involves enzyme-catalyzed conversion of the hydrazine to the
diazene. From literature data on the reactivities of diazenes, O2 then reacts
with the bound diazene to form an alkyl radical, N2 and superoxide anion. The
bound arylalkyl radical reacts with the N(5) of the flavin, while the
dissociated diazene reacts nonspecifically with the enzyme through
arylalkylradicals.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.E.Edmondson,
C.Binda,
J.Wang,
A.K.Upadhyay,
and
A.Mattevi
(2009).
Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases.
|
| |
Biochemistry, 48,
4220-4230.
|
 |
|
|
|
|
 |
M.Naoi,
and
W.Maruyama
(2009).
Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.
|
| |
Expert Rev Neurother, 9,
1233-1250.
|
 |
|
|
|
|
 |
E.M.Milczek,
D.Bonivento,
C.Binda,
A.Mattevi,
I.A.McDonald,
and
D.E.Edmondson
(2008).
Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B.
|
| |
J Med Chem, 51,
8019-8026.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|